-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Fcs80LaJcWsWtRLpikVDyh/bKU9lro86AoyPsqsK0JTPo8ItKpmbiYTy8tWPaBGv yDB2Dyqh+YM5pvCY09Yowg== 0001021408-02-001123.txt : 20020414 0001021408-02-001123.hdr.sgml : 20020414 ACCESSION NUMBER: 0001021408-02-001123 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020129 ITEM INFORMATION: Other events FILED AS OF DATE: 20020130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SALIX PHARMACEUTICALS LTD CENTRAL INDEX KEY: 0001009356 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943267443 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23265 FILM NUMBER: 02521601 BUSINESS ADDRESS: STREET 1: 8540 COLONNADE CENTER DR STREET 2: SUITE 501 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 9198621000 MAIL ADDRESS: STREET 1: 8540 COLONNADE CENTER DR STREET 2: SUITE 501 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: SALIX HOLDINGS LTD DATE OF NAME CHANGE: 19970807 8-K 1 d8k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 29, 2002 SALIX PHARMACEUTICALS, LTD. -------------------------------------------------------------------- (Exact name of registrant as specified in its charter) Delaware -------- (State or other jurisdiction of incorporation) 000-23265 94-3267443 - ------------------------------ ------------------------------- (Commission file Number) (IRS Employer ID Number) 8540 Colonnade Center Drive, Suite 501, Raleigh, North Carolina 27615 - -------------------------------------------------------------------------------- (Address of principal executive offices) Zip Code) Registrant's telephone number, including area code (919) 862-1000 ---------------------------- Item 5. Other Events Emerald Asset Management, Inc. issued a press release on January 29, 2002 to announce that Salix Pharmaceuticals will be presenting at the Ninth Annual Emerald Groundhog Day Investment Forum, scheduled for Tuesday, February 5, 2002 at the Wyndham Franklin Plaza Hotel in Philadelphia. Emerald will provide an audio feed of the entire Forum via their Internet website at www.teamerald.com. In addition, Salix's presentation will be broadcast live and - ----------------- will be available for replay following the Forum. For broadcast and replay information, contact the Emerald Internet website at www.teamerald.com. ----------------- SIGNATURES ---------- Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SALIX PHARMACEUTICALS, LTD. Date: January 29, 2002 By: /s/ Adam C. Derbyshire ---------------------- Adam C. Derbyshire Vice President and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----